Jayakar, V. (2014). Using 2(nd) generation tyrosine kinase inhibitors in frontline management of chronic phase chronic myeloid leukemia. Medknow Publications & Media Pvt Ltd.
Stile di citazione ChicagoJayakar, Vishal. Using 2(nd) Generation Tyrosine Kinase Inhibitors in Frontline Management of Chronic Phase Chronic Myeloid Leukemia. Medknow Publications & Media Pvt Ltd, 2014.
Citazione MLAJayakar, Vishal. Using 2(nd) Generation Tyrosine Kinase Inhibitors in Frontline Management of Chronic Phase Chronic Myeloid Leukemia. Medknow Publications & Media Pvt Ltd, 2014.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.